IvyRock Asset Management HK Ltd Makes New Investment in Direxion Daily S&P Biotech Bull 3x Shares $LABU

IvyRock Asset Management HK Ltd purchased a new stake in Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABUFree Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 8,200 shares of the company’s stock, valued at approximately $768,000. Direxion Daily S&P Biotech Bull 3x Shares comprises 0.3% of IvyRock Asset Management HK Ltd’s investment portfolio, making the stock its 9th biggest position. IvyRock Asset Management HK Ltd owned approximately 0.13% of Direxion Daily S&P Biotech Bull 3x Shares at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. Spire Wealth Management grew its holdings in Direxion Daily S&P Biotech Bull 3x Shares by 46.3% during the 2nd quarter. Spire Wealth Management now owns 1,106 shares of the company’s stock valued at $63,000 after buying an additional 350 shares during the last quarter. Ethos Financial Group LLC lifted its position in shares of Direxion Daily S&P Biotech Bull 3x Shares by 33.5% in the second quarter. Ethos Financial Group LLC now owns 9,055 shares of the company’s stock valued at $515,000 after acquiring an additional 2,270 shares in the last quarter. Allworth Financial LP boosted its stake in shares of Direxion Daily S&P Biotech Bull 3x Shares by 1,777.8% during the second quarter. Allworth Financial LP now owns 4,225 shares of the company’s stock valued at $240,000 after acquiring an additional 4,000 shares during the last quarter. SBI Securities Co. Ltd. increased its position in Direxion Daily S&P Biotech Bull 3x Shares by 12.8% during the 2nd quarter. SBI Securities Co. Ltd. now owns 3,388 shares of the company’s stock worth $193,000 after purchasing an additional 385 shares in the last quarter. Finally, SG Americas Securities LLC increased its position in Direxion Daily S&P Biotech Bull 3x Shares by 21.7% during the 2nd quarter. SG Americas Securities LLC now owns 3,561 shares of the company’s stock worth $203,000 after purchasing an additional 635 shares in the last quarter.

Direxion Daily S&P Biotech Bull 3x Shares Stock Performance

NYSEARCA:LABU opened at $176.87 on Thursday. Direxion Daily S&P Biotech Bull 3x Shares has a 12-month low of $32.55 and a 12-month high of $198.18. The company’s 50-day moving average is $168.24 and its two-hundred day moving average is $130.71.

About Direxion Daily S&P Biotech Bull 3x Shares

(Free Report)

The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.

Read More

Want to see what other hedge funds are holding LABU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABUFree Report).

Institutional Ownership by Quarter for Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU)

Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.